Pulse oximetry as a screening test for congenital heart defects in newborn infants: A cost-effectiveness analysis

Archives of Disease in Childhood

Volumn 97, Issue 3, 2012, Pages 221-226

  Roberts, Tracy E ^a   Barton, P M ^a   Auguste, P E ^a   Middleton, L J ^a   Furmston, A T ^a   Ewer, A K ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; CONGENITAL HEART MALFORMATION; COST EFFECTIVENESS ANALYSIS; HOSPITAL DISCHARGE; HUMAN; LIVE BIRTH; NEWBORN; NEWBORN SCREENING; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; PULSE OXIMETRY; QUALITY OF LIFE;

COST-BENEFIT ANALYSIS; GREAT BRITAIN; HEALTH CARE COSTS; HEALTH RESOURCES; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; MODELS, ECONOMETRIC; NEONATAL SCREENING; OXIMETRY;

EID: 84857232527     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-300564     Document Type: Article

References (12)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-181.
2. Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed 2008;93:F33-5.
3. Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001;107:E32.
4. Ewer AK, Middleton LJ, Furmston AT, et al. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet 2011;378:785-94.
5. Knowles R, Griebsch I, Dezateux C, et al. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health Technol Assess 2005;9:1-152, iii-iv.
6. Wren C, Richmond S, Donaldson L. Temporal variability in birth prevalence of cardiovascular malformations. Heart 2000;83:414-9. (Pubitemid 30316755)
7. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986;5:1-30. (Pubitemid 16098443)
8. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000;320:1197-200. (Pubitemid 30224273)
9. Curtis L. Unit Costs of Health & Social Care. Personal Social Services Research Unit, 2009.
10. de-Wahl Granelli A, Wennergren M, Sandberg K, et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ 2009;338:a3037.
11. Richmond S, Reay G, Abu Harb M. Routine pulse oximetry in the asymptomatic newborn. Arch Dis Child Fetal Neonatal Ed 2002;87:F83-8. (Pubitemid 34971780)
12. Meberg A, Brügmann-Pieper S, Due R Jr, et al. First day of life pulse oximetry screening to detect congenital heart defects. J Pediatr 2008;152:761-5.